In the last trading session, 3.21 million Microbot Medical Inc (NASDAQ:MBOT) shares changed hands as the company’s beta touched 1.16. With the company’s per share price at $2.68 changed hands at $0.01 or 0.37% during last session, the market valuation stood at $97.49M. MBOT’s last price was a discount, traded about -26.12% off its 52-week high of $3.38. The share price had its 52-week low at $0.82, which suggests the last value was 69.4% up since then.
Analysts gave the Microbot Medical Inc (MBOT) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 1 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended MBOT as a Hold, 1 felt it is a Buy and 0 rated the stock as Underweight. Microbot Medical Inc’s EPS for the current quarter is expected to be -0.12.
Microbot Medical Inc (NASDAQ:MBOT) trade information
Instantly MBOT was in green as seen at the end of in last trading. With action 6.35%, the performance over the past five days has been green. The company’s shares are showing year-to-date upside of 139.29%, with the 5-day performance at 6.35% in the green. However, in the 30-day time frame, Microbot Medical Inc (NASDAQ:MBOT) is 8.94% up.
1 analysts are of the opinion that Microbot Medical Inc’s revenue for the current quarter will be 2M. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 0.00%. The estimates for the next quarter sales put growth at 0.00%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 15.51%. The 2025 estimates are for Microbot Medical Inc earnings to increase by 45.21%.
MBOT Dividends
Microbot Medical Inc is expected to release its next quarterly earnings report in June.
BLACKROCK INC. holds the second largest percentage of outstanding shares, with 0.9253% or 0.14 million shares worth $0.14 million as of 2024-06-30.
Among Mutual Funds, the top two as of Dec 31, 2024 were VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and Fidelity Concord Street Trust-Fidelity Extended Market Index Fund . With 348.55 shares estimated at $0.93 million under it, the former controlled 1.00% of total outstanding shares. On the other hand, Fidelity Concord Street Trust-Fidelity Extended Market Index Fund held about 0.52% of the shares, roughly 180.3 shares worth around $0.48 million.
